News
Functional capacity, life skills critical for patients with schizophrenia
Adults with schizophrenia need treatment that goes beyond antipsychotics, researchers say.
News
Experts cite five orthopedic tests that physicians and patients should question
Orthopedic experts share their knowledge about overutilized procedures.
News
Sleep disturbance not linked to age or IQ in early ASD
Why do some young children with autism experience disrupted sleep patterns? More study is needed.
News
Biologics have best chance of achieving PASI 90 in psoriasis
Results derived from a meta-analysis of 109 randomized, controlled trials contrast with real-world treatment recommendations.
News
More time with digital media impacts childhood well-being
Parents perceive that more media time has a negative impact on their children.
News
CV risk factors go undiagnosed, untreated in many psoriatic patients
Study of more than 2,000 patients at eight centers in Canada, the United States, and Israel.
News
Hernia repair patients had less pain with lightweight mesh
Patients reported having less pain 1 year after hernia repair with lightweight mesh than with heavy mesh.
News
FDA approves implantable therapy for PAH
PAH patients now have access to an implantable system designed to help supply blood to the lungs and keep a patient’s blood pressure within a...
News
FDA issues safety alert for loperamide
Abuse of loperamide tied to opioid epidemic
News
FDA approves lutetium Lu 177 dotatate for GEP-NETs
This is the first approval of a radiopharmaceutical for gastroenteropancreatic neuroendocrine tumors.
News
FDA grants ‘Breakthrough Therapy Designation’ for upadacitinib for atopic dermatitis
Special status given to drug to treat adult patients with moderate to severe atopic dermatitis who are candidates for systemic therapy.
News
FDA approves injection treatment for low-risk APL
The expanded indication allows for first-line treatment for adults with newly diagnosed low-risk acute promyelocytic leukemia.
News
FDA grants breakthrough therapy designation for severe aplastic anemia drug
Eltrombopag, from Novartis, will get expedited review for first-line treatment of severe aplastic anemia. It is already approved as a second-line...
News
Autologous stem-cell transplantation for scleroderma beats cyclophosphamide in long term
Hematopoietic toxicity should be weighed against the benefits of transplantation.
News
FDA approves tofacitinib for psoriatic arthritis
The drug is now the only Janus kinase inhibitor approved to treat psoriatic arthritis.